Fail First: The Insurance Playbook That Makes Patients Suffer Through the Wrong Medication Before Getting the Right One

The Prescription Your Doctor Wrote Is Not Always the Prescription You Will Receive

When a physician writes a prescription, the assumption is straightforward: a trained clinician has assessed the patient, weighed the evidence, and selected the most appropriate treatment. What many patients do not realize is that a second decision-maker—their insurance company—frequently intervenes between that clinical judgment and the pharmacy counter.

This intervention takes the form of step therapy, sometimes called "fail first" policy. Under this approach, an insurer will refuse to cover a prescribed medication until the patient has first tried one or more cheaper alternatives—typically older generic drugs—and demonstrated that those alternatives have failed. Only after that documented failure will the insurer authorize coverage for the drug the physician originally recommended.

The result is a system in which patients are, by design, required to experience inadequate treatment before accessing the care their doctor believes they need.

How Step Therapy Actually Works—and Why Insurers Use It

Formularies are the tiered lists of medications that insurance plans agree to cover. Drugs placed on higher tiers carry higher out-of-pocket costs; drugs on lower tiers are cheaper for both the insurer and, in theory, the patient. Step therapy is the enforcement mechanism that keeps patients on lower-tier drugs for as long as possible.

From an insurer's perspective, the logic is not without merit. Many conditions—high blood pressure, depression, certain autoimmune disorders—can be effectively managed with generic medications that cost a fraction of newer branded alternatives. If a generic works, the argument goes, there is no clinical reason to pay significantly more for a branded equivalent.

The problem is that medicine is rarely that uniform. Individual patients metabolize drugs differently. A generic antidepressant that resolves symptoms for one patient may cause intolerable side effects or provide no benefit whatsoever for another. A blood pressure medication that controls hypertension effectively in most people may interact poorly with a specific patient's kidney function or existing drug regimen. Physicians account for these variables when they prescribe. Formulary algorithms do not.

The Clinical Cost of Forced Substitution

The consequences of step therapy extend well beyond inconvenience. In mental health treatment, forcing patients through multiple medication trials before reaching an effective regimen can mean months of uncontrolled symptoms—depression deepening, anxiety escalating, or psychotic episodes going inadequately managed. In autoimmune conditions such as rheumatoid arthritis or Crohn's disease, delayed access to appropriate biologic therapy can allow irreversible joint damage or intestinal scarring to progress during the waiting period.

Endocrinologists treating complex diabetes cases have reported similar frustrations. A patient whose physician has identified a specific combination of medications as necessary for adequate glucose control may spend weeks on a formulary-preferred alternative, experiencing poor glycemic management and the attendant risks before an exception is eventually granted.

These are not hypothetical concerns. Research published in peer-reviewed journals has documented associations between step therapy requirements and increased emergency department visits, hospitalizations, and worsening disease outcomes—particularly among patients with chronic conditions requiring stable, consistent medication regimens.

The Bureaucratic Burden Falls on the Patient

When step therapy fails—as it is, in some sense, designed to do before coverage is granted—the patient bears the weight of the appeals process. Physicians must submit detailed documentation of the failed trials, write letters of medical necessity, and in many cases participate in peer-to-peer reviews with insurance company physicians who may have limited familiarity with the specific condition being treated.

This process can take days, weeks, or longer. During that time, patients are left without effective treatment, often managing symptoms as best they can while navigating a system that was not designed with their welfare as the primary variable.

For patients who rely on a single local pharmacy, each step of this process may also involve repeated trips—picking up the formulary-preferred drug, returning when it proves ineffective, waiting for authorization paperwork to clear, then returning again once the exception is approved. The physical and logistical toll compounds the clinical one.

State Protections Exist—But Awareness Is Low

A growing number of states have enacted step therapy reform legislation that places limits on how long insurers can require patients to remain on a failing medication before granting an exception. Many of these laws also establish expedited review timelines for urgent cases and require insurers to honor step therapy exceptions granted by previous plans—a provision known as "continuity of care" protection.

Federally, the Improving Seniors' Timely Access to Care Act, signed into law in 2022, introduced new step therapy standards for Medicare Advantage plans, including requirements for faster exception decisions and greater transparency around formulary restrictions.

Despite these protections, patient awareness remains limited. Many individuals do not know their state has enacted reform legislation, and fewer still know how to invoke those protections effectively. Understanding the appeals process—and initiating it early—can materially shorten the time spent on inadequate treatment.

Practical Steps When Your Insurer's Drug Is Not Working

If you find yourself caught in a step therapy requirement, the following strategies can help move the process forward.

Document everything from the start. Every side effect, every symptom that persists or worsens, every dose adjustment—keep a written log with dates. This documentation forms the foundation of any exception request and demonstrates, concretely, that the formulary-preferred medication has failed.

Ask your physician to submit a prior authorization request immediately. Do not wait until the insurer's required trial period concludes if you are experiencing significant adverse effects. Many insurers will consider an expedited exception based on documented clinical harm.

Request a peer-to-peer review. This is a direct conversation between your physician and the insurance company's medical reviewer. Studies suggest that peer-to-peer reviews result in authorization approval at higher rates than written appeals alone.

Know your state's step therapy laws. Your state insurance commissioner's website is a reliable starting point. If your state has enacted reform legislation, cite it explicitly in any appeal correspondence.

Ask about manufacturer patient assistance programs. If you need the prescribed medication immediately and coverage is delayed, the drug's manufacturer may offer a bridge program or copay assistance that reduces out-of-pocket costs during the appeals period.

The Role of Medication Continuity During an Appeal

One of the underappreciated challenges of step therapy appeals is logistical. Patients who are switching between medications—or waiting for authorization on a new one—often find themselves making repeated trips to a local pharmacy, each visit representing a disruption to an already stressful process.

Home delivery of prescription medications offers a practical advantage in these circumstances. When a formulary-preferred drug is dispensed and later replaced by an approved exception, having medications delivered directly removes one layer of friction from an already demanding process. More broadly, patients managing chronic conditions who have established a home delivery relationship with a pharmacy service are better positioned to maintain consistent access when their regimen changes—whether due to step therapy resolution, formulary updates, or physician-directed adjustments.

At MedDelivered, we recognize that medication access is rarely a simple transaction. For patients navigating the complexity of insurance formularies and step therapy requirements, consistent, flexible delivery is one less obstacle in an already difficult path.

The Prescription Should Reflect the Patient, Not the Formulary

Step therapy policies reflect a genuine tension within the American healthcare system: the need to manage costs at scale versus the need to treat individual patients as individuals. Neither concern is illegitimate. But when the balance tips too far toward cost containment—when patients are required to suffer through ineffective treatment before accessing what their physician prescribed—the system has lost sight of its fundamental purpose.

Understanding how these policies work, knowing your rights under state and federal law, and acting quickly when a prescribed medication is blocked are the most effective tools available to patients today. The pharmacy gauntlet is real. So, increasingly, are the means to navigate it.